Bora Pharmaceuticals is a premier CDMO specializing in complex oral solid dose, modified release, liquids, semi-solids, nasal sprays, biologics and ophthalmics, for pharmaceutical Rx and OTC products. Bora offers flexible biologics and cGMP manufacturing solutions to biologics developers. Bora has 6 manufacturing sites in North America and Taiwan.
Bikash Chatterjee of Pharmatech Associates discusses the reshoring trend, technologies and advances that could help deliver more manufacturing back to the U.S.
Veklury (remdesivir) with sales of $829 million offsets loss of exclusivity of Truvada and Atripla in the U.S. with sales down 72% and 42%, respectively.
Biovac will perform manufacturing and distribution activities within Pfizer’s and BioNTech’s global COVID-19 vaccine supply chain and manufacturing network.
CDMOs have been some of the biggest winners from COVID contracts and will see benefits for several more years to come. A Q&A with GlobalData’s Peter Shapiro.
Lonza’s Robert Beland discusses best practices for manufacturers to shorten development timelines, as well as some of the capabilities at the CDMO's Tampa site.
How today’s life sciences manufacturers can effectively monitor processes, integrate with sub-contractors and align with regulatory reporting requirements.
Dr. Murphy of ICON, provider of clinical services to Pfizer/BioNTech’s COVID vaccine program, discusses what it takes to conduct a vaccine trial of this scale.
As a partner to the U.S. Government, GRAM's newest facility was designed to increase large-scale fill and finish capacity with room to expand as demand grows.
Fran L. DeGrazio of West discusses why and how vaccine development is different than drug development and the impacts of COVID-19 on vaccine development.
Dr. Ural of Ernst & Young LLP discusses market dynamics, enduring therapeutic areas, near term M&A, and how industry can use this time for transformation
Serge Bodart of IDDI provides insight on the pharma and biopharma trends impacting CROs, outsourcing in today’s market, and advances in clinical research.
JoyL Silva of Pfizer CentreOne discusses global market and regulatory changes driving drug development strategies and the evolution of CDMO services and ops.
Andrew Kolbert of Avomeen discusses FDA oversight of E&L testing, complications that arise, and the expertise needed to keep up with changing quality standards
Senior Product Manager, Ben Wylie, sat down with Contract Pharma to discuss new company developments and technology, along with emerging industry trends
The chief executive talks industry trends, challenges and what’s in store for PCI Pharma Services as it continues its rapid growth and global expansion strategy
Michael Felo, Director, Downstream Process Integration, Next Generation Processing, MilliporeSigma shares his insight with Contract Pharma at Interphex 2019
The use of electronic tongue technology helps firms reduce development times and costs by overcoming challenges associated with traditional testing panels.
Detlev Haack & Martin Koeberle, Hermes Pharma03.06.19
IDDI, BMS Consortium aims to establish that the GPC statistical method can complement the design, analysis and interpretation of clinical trial results
A roundtable discussion about the serialization challenge and why some contract service providers and brand owners are skeptical of each other's readiness
Contract Pharma asked a roundtable of business leaders from Symbiosis, Grifols, Althea, LSNE and Baxter to discuss key trends in the parenteral dosage development and manufacturing market
Niall Dinwoodie of Charles River discusses several key industry issues on biosimilars and addresses some of the development and regulatory hurdles that remain
Pharma teamed up with ICON, Tufts CSDD and other industry players to author new book detailing holistic reforms for trial design, clinical ops, and portfolios
KPMG Strategy’s Mark Ginestro discusses the impact of biosimilars after the FDA’s recent approval of filagrastim, and what drug makers should anticipate
Getting packaged investigational materials dispensed to the patients taking part in clinical trials, on time and correctly, requires orchestrating myriad activities. This is the second in a series of articles outlining specific quality concerns associated with packaging clinical trial supplies and how to effectively manage those concerns.
Where FMEA, fault tree and other risk management methods drill down to the tiniest detail, Bow Tie methods allow for a broader view of risk throughout the enterprise.
You may know FMEA, Fault Tree and Fishbone methods, but do you know Bow-Tie risk assessment practices? Proven in aerospace and oil & gas industries, they can help strengthen top management connection to key areas of potential vulnerability.
Would you like to share your expertise in a case study or best practices article, or even just share a brief opinion in a blog post or commentary? Please consider writing for the Contract Pharma community. We've just updated our Writers' Guidelines to provide more input on graphics, and even received some unexpected help from a brand new expert named Al Yankovic.
Hiring is up, recruiters say, and soft skills are in short supply. Survey respondents say they’re happy now, but will likely change employers within five years.
Review the business development cycle in the custom manufacturing industry and assess risks associated with pharmaceutical fine chemicals manufacturing
Peter Pollak and Andrew Badrot, CMS Pharma10.09.13
Welcome to Contract Pharma’s Fourteenth Annual Salary Survey! This year’s results are derived from nearly 500 respondents from our readership about employment attitudes, responsibilities, education, and their 2012 salaries.
Welcome to Contract Pharma’s Fourteenth Annual Salary Survey! This year’s results are derived from nearly 500 respondents from our readership about employment attitudes, responsibilities, education, and their 2012 salaries.
Welcome to our 9th Annual Contract Pharma Outsourcing Survey! More than 200 sponsor-side respondents offered up their opinions on outsourcing trends for this year's poll.
Welcome to Contract Pharma’s Thirteenth Annual Salary Survey! This year’s results are derived from nearly 650 respondents from our readership about employment attitudes, responsibilities, education, and their 2011 salaries.
Welcome to our 8th Annual Contract Pharma Outsourcing Survey! More than 200 sponsor-side respondents offered up their opinions on outsourcing trends for this year's poll. Here's a breakdown of the respondents, by company type & job function:
WELCOME TO Contract Pharma’s Twelfth Annual Salary Survey! This year’s results are derived from nearly 700 respondents from our readership about employment attitudes, responsibilities, education, and their 2010 salaries.
WELCOME TO Contract Pharma’s Twelfth Annual Salary
Survey! This year’s results are derived from nearly
700 respondents from our readership about employment
attitudes, responsibilities, education, and their 2010
salaries.
Welcome to our 7th Annual Contract Pharma Outsourcing Survey! More than 200 sponsor-side respondents offered up their opinions on outsourcing trends for this year's poll. Here's a breakdown of the respondents, by company type & job function:
Welcome to our 7th Annual Contract Pharma Outsourcing Survey! More than 200 sponsor-side respondents offered up their opinions on outsourcing trends for this year's poll.
Argenta, a service division of Galapagos NV, has signed a contract extension with Genentech, allowing projects to be assigned to Galapagos’ service division, BioFocus.
DSM BioSolutions, DSM’s microbial fermentation CMO business unit, and PolyTherics Ltd. have entered into an agreement for the process development and manufacture of PolyTherics’ lead “biobetter” product, HiPEG IFN α-2a.
TraceLink and Patheon have entered into a strategic partnership aimed at improving visibility and collaboration for life science companies across their entire product manufacturing and packaging lifecycle.
Genzyme Corp. expects changes requested by the FDA after a contamination at its Allston plant to take as many as four years longer than previously projected.
Catalent Pharma Solutions has released its Optiform compound optimization platform, a solid-state and highly-automated analysis platform for salt, crystal-form, and co-crystal screening.
Almac has launched Biomarkers for biopharma, a range of solutions to support biopharma companies in adopting biomarker strategies to help them better understand their drugs, improve success rates and values, and maximize the drugs’ potentials.
Mary Foster, Pharm.D., vice president of Quality at Catalent, has been elected chair of the United States Pharmacopeia (USP) Packaging, Storage and Distribution Expert Committee for the 2010-2015 USP cycle.
Penn Pharma and Xcelience, LLC have entered into a joint venture agreement to provide Capsugel’s Xcelodose precision powder micro-dosing system technology on a global basis.
TraceLink, Inc. and Catalent Pharma Solutions have entered a partnership aimed at improving production visibility for Catalent customers across their entire manufacturing and packaging product lifecycle.
Welcome to Contract Pharma’s Eleventh Annual Salary Survey! This year’s results are derived from 600 respondents from our readership about employment attitudes, responsibilities, education, and their 2009 salaries.
Welcome to our 6th Annual Contract Pharma Outsourcing Survey! More than 350 sponsor-side respondents offered up their opinions on outsourcing trends for this year’s poll. Here’s a breakdown of the respondents, by company type & job function:
Welcome to our 6th Annual Contract Pharma Outsourcing Survey! More than 350 sponsor-side respondents offered up their opinions on outsourcing trends for this year’s poll. Here’s a breakdown of the respondents, by company type & job function:
Kincannon & Reed Global Executive Search, a global recruiting firm, has named David G. Jensen to the newly created position of managing director, Biopharmaceutical Life Sciences.
Welcome to the Tenth Annual Contract Pharma Salary Survey! This year’s results are derived from 457 respondents from our readership about employment attitudes, responsibilities, education, and salaries.
Welcome to our 5th Annual Contract Pharma Outsourcing Survey! More than 175 sponsor-side respondents offered up their opinions on outsourcing trends for this year's poll. Here's a breakdown of respondents by company type:
Welcome to the Ninth Annual Contract Pharma Salary Survey! This year’s results are derived from 450 respondents from our readership about employment attitudes, responsibilities, education, and salaries.
Welcome to the Ninth Annual Contract Pharma Salary Survey! This year’s results are derived from 450 respondents from our readership about employment attitudes, responsibilities, education, and salaries.
Welcome to our 3rd Annual Contract Pharma Outsourcing Survey! More than 200 sponsor-side respondents offered up their opinions on outsourcing trends for this year's poll. Here's a breakdown of the respondents by company type:
Welcome to the Eighth Annual Contract Pharma Salary Survey! This year’s results are derived from 750 respondents from our readership about employment attitudes, responsibilities, education, and salaries.
Welcome to the Eighth Annual Contract Pharma Salary Survey! This year’s results are derived from 750 respondents from our readership about employment attitudes, responsibilities, education, and salaries.
Welcome to our 3rd Annual Contract Pharma Outsourcing Survey! More than 200 sponsor-side respondents offered up their opinions on outsourcing trends for this year's poll. Here's a breakdown of the respondents by company type:
Welcome to the Seventh annual Contract Pharma Salary Survey! This year’s results are derived from 487 respondents from our readership about employment attitudes, responsibilities, education, and salaries.
The parenteral drug sector is driven by new cancer drugs and a considerable number of biologics. Veteran performers, like Baxter Biopharma, brace for growth.
Our editorial staff has gathered information from annual reports, interviews, and analyst coverage to compile a list of the previous year's Top 20 players in the Pharma arena.
Contract Pharma and Nutraceuticals World offer a supplemental issue with articles on Raw Materials Methodology Transfer and Ventilation Enclosures for Dust Containment, as well as an extended Reader Showcase section